ODTX — Odyssey Therapeutics Share News
0.000.00%
Last trade - 00:00- $1.16bn
- $853.28m
- $2.98m
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut (updated)
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut
NASDAQ RESUMED AT 11:51 AM
NASDAQ RESUMED AT 11:08 AM
NASDAQ TRADE HALT IPO SECURITY RELEASED FOR QUOTATION AT 11:08 AM
NASDAQ TRADE HALT IPO SECURITY RELEASED FOR QUOTATION AT 11:06 AM
NASDAQ RESUMED AT 11:06 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Biotech firm Odyssey raises $279 million in upsized US IPO (updated)
Biotech firm Odyssey raises $279 million in upsized US IPO
Brief: Odyssey Therapeutics Announces Pricing Of Upsized Initial Public Offering
Biotech firm Odyssey targets $810 million valuation in US IPO (updated)
Brief: Odyssey Therapeutics Inc - Announces Initial Public Offering Of Common Stock - SEC Filing